Volume 5, Issue 1, Pages 7-16 (July 1996)

Slides:



Advertisements
Similar presentations
The Roles of Fas/APO-1 (CD95) and TNF in Antigen-Induced Programmed Cell Death in T Cell Receptor Transgenic Mice Huey-Kang Sytwu, Roland S Liblau, Hugh.
Advertisements

Volume 39, Issue 3, Pages (September 2013)
Peptide Immunization Indicates that CD8+ T Cells are the Dominant Effector Cells in Trinitrophenyl-Specific Contact Hypersensitivity  Stefan Martin, Michael.
Upregulation of Inflammatory Cytokines and Oncogenic Signal Pathways Preceding Tumor Formation in a Murine Model of T-Cell Lymphoma in Skin  Xuesong Wu,
The Roles of Fas/APO-1 (CD95) and TNF in Antigen-Induced Programmed Cell Death in T Cell Receptor Transgenic Mice  Huey-Kang Sytwu, Roland S Liblau, Hugh.
Biochemical Mechanisms of IL-2–Regulated Fas-Mediated T Cell Apoptosis
Antigen-Specific Peripheral Tolerance Induced by Topical Application of NF-κB Decoy Oligodeoxynucleotide  Iwao Isomura, Kunio Tsujimura, Akimichi Morita 
Interaction of HSV-1 Infected Peripheral Blood Mononuclear Cells with Cultured Dermal Microvascular Endothelial Cells: a Potential Model for the Pathogenesis.
Prevention of Genital Herpes Simplex Virus Type 1 and 2 Disease in Mice Immunized with a gD-Expressing Dominant-Negative Recombinant HSV-1  Richard Brans,
Volume 11, Issue 5, Pages (November 1999)
Langerhans Cells Are Required for UVR-Induced Immunosuppression
Volume 21, Issue 5, Pages (November 2004)
Volume 29, Issue 1, Pages (July 2008)
Nitric oxide from rat liver sinusoidal endothelial cells induces apoptosis in IFN γ- sensitized CC531s colon carcinoma cells  Katrien Vekemans, Filip Braet,
Volume 26, Issue 2, Pages (February 2018)
Volume 28, Issue 2, Pages (February 2008)
James I Kim, I-Cheng Ho, Michael J Grusby, Laurie H Glimcher  Immunity 
Volume 6, Issue 5, Pages (May 1997)
Rafael Gongora, Robert P Stephan, Zhixin Zhang, Max D Cooper  Immunity 
Toshiyuki Yamamoto, Kiyoshi Nishioka 
Volume 14, Issue 1, Pages (January 2001)
Thomas S. Griffith, Thomas A. Ferguson  Immunity 
Topical Imiquimod Treatment Prevents UV-Light Induced Loss of Contact Hypersensitivity and Immune Tolerance  Thomas H. Thatcher, Irina Luzina, Rita Fishelevich,
Volume 15, Issue 1, Pages (July 2001)
Shiou-Hwa Jee  Journal of Investigative Dermatology 
Volume 29, Issue 6, Pages (December 2008)
Volume 7, Issue 6, Pages (December 1997)
Volume 11, Issue 1, Pages (July 1999)
Volume 33, Issue 4, Pages (October 2010)
Volume 19, Issue 5, Pages (November 2003)
Contact Hypersensitivity in MHC Class II-Deficient Mice Depends on CD8 T Lymphocytes Primed by Immunostimulating Langerhans Cells  Anne Bouloc, Andrea.
Volume 8, Issue 5, Pages (May 1998)
Fateh Ouaaz, Joseph Arron, Ye Zheng, Yongwon Choi, Amer A Beg  Immunity 
Thomas S. Griffith, Elizabeth L. Broghammer  Molecular Therapy 
Timothy J. Paradis, Susan H. Cole, Robin T. Nelson, Ronald P. Gladue 
Volume 25, Issue 1, Pages (January 2017)
Aloe Barbadensis Extracts Reduce the Production of Interleukin-10 After Exposure to Ultraviolet Radiation  Son Won Byeon  Journal of Investigative Dermatology 
Volume 8, Issue 3, Pages (January 1998)
Agatha Schwarz, Anika Bruhs, Thomas Schwarz 
Urocanic Acid: An Endogenous Regulator of Langerhans Cells
Volume 16, Issue 4, Pages (April 2002)
LAT Links the Pre-BCR to Calcium Signaling
Volume 117, Issue 5, Pages (November 1999)
Selective Upregulation of Fibroblast Fas Ligand Expression, and Prolongation of Fas/Fas Ligand-Mediated Skin Allograft Survival, by Retinoic Acid: the.
Infrared Radiation Confers Resistance to UV-Induced Apoptosis Via Reduction of DNA Damage and Upregulation of Antiapoptotic Proteins  Christian Jantschitsch,
IL-23 Antagonizes UVR-Induced Immunosuppression through Two Mechanisms: Reduction of UVR-Induced DNA Damage and Inhibition of UVR-Induced Regulatory T.
Volume 2, Issue 5, Pages (November 2012)
Hidetoshi Takahashi, Akemi Ishida-Yamamoto, Hajime Iizuka 
Volume 4, Issue 6, Pages (June 1996)
No defect in T-cell priming, secondary response, or tolerance induction in response to inhaled antigens in Fms-like tyrosine kinase 3 ligand–deficient.
Keratinocyte Apoptosis Induced by Ultraviolet B Radiation and CD95 Ligation – Differential Protection through Epidermal Growth Factor Receptor Activation.
Zebrafish as a Model Organism for the Identification and Characterization of Drugs and Genes Affecting p53 Signaling  Ulrike Langheinrich, Elisabeth Hennen,
Volume 8, Issue 2, Pages (August 2003)
Luk Van Parijs, Alexander Ibraghimov, Abul K. Abbas  Immunity 
Volume 18, Issue 3, Pages (March 2003)
CpG Immunostimulatory Sequences Enhance Contact Hypersensitivity Responses in Mice  Hitoshi Akiba, Masataka Satoh, Keiji Iwatsuki, Dominique Kaiserlian,
Interleukin-10-Treated Dendritic Cells Modulate Immune Responses of Naive and Sensitized T Cells In Vivo  Gabriele Müller, Anke Müller  Journal of Investigative.
Volume 9, Issue 5, Pages (November 1998)
Volume 8, Issue 3, Pages (August 2014)
Patrizia Stoitzner, Christoph H
Volume 2, Issue 4, Pages (October 2002)
Hapten-Specific Tolerance Promoted by Calcitonin Gene-Related Peptide
Induction of apoptosis by NS398.
Regulation of the Th2 Cytokine Locus by a Locus Control Region
Memory CD8+ T Cells Undergo Peripheral Tolerance
Inhibition of NF-κB in cancer cells converts inflammation- induced tumor growth mediated by TNFα to TRAIL-mediated tumor regression  Jun-Li Luo, Shin.
Repulsive Guidance Molecule-a Is Involved in Th17-Cell-Induced Neurodegeneration in Autoimmune Encephalomyelitis  Shogo Tanabe, Toshihide Yamashita  Cell.
Volume 25, Issue 3, Pages (September 2006)
Volume 20, Issue 6, Pages (June 2004)
Volume 10, Issue 3, Pages (March 1999)
Presentation transcript:

Volume 5, Issue 1, Pages 7-16 (July 1996) CD95-Induced Apoptosis of Lymphocytes in an Immune Privileged Site Induces Immunological Tolerance  Thomas S Griffith, Xinhong Yu, John M Herndon, Douglas R Green, Thomas A Ferguson  Immunity  Volume 5, Issue 1, Pages 7-16 (July 1996) DOI: 10.1016/S1074-7613(00)80305-2

Figure 1 Effect of Enucleation on Tolerance Induction B6 mice were injected AC with 2.5 × 104 pfu of HSV-1. On days 1, 2, 3, and 4 eyes were removed. On day 7, mice were challenged with 106 pfu UV-inactivated virus in 0.033 ml PBS in the right foot- pad and 0.033 ml PBS in the left footpad. Measurements (micro- meters ± standard error) were taken 24 hr later and represent the difference between right footpad (antigen challenge) and left footpad (PBS challenge). Background (Bkg) values represent the difference between challenged and unchallenged sites in naive mice. Immunity 1996 5, 7-16DOI: (10.1016/S1074-7613(00)80305-2)

Figure 2 Immune Tolerance in B6–lpr or B6–gld Mice B6–lpr (A), B6–gld (B), or B6 mice were immunized with 2.5 × 104 pfu of HSV-1 either AC or subcutaneously. They were challenged 7 days later with 106 pfu UV-inactivated virus in 0.033 ml PBS in the right footpad and 0.033ml PBS in the left footpad. Measurements (micrometers ± standard error) were taken 24 hr later and represent the difference between right footpad (antigen challenge) and left footpad (PBS challenge). Background (Bkg) values represent the difference between challenged and unchallenged sites in naive mice. Immunity 1996 5, 7-16DOI: (10.1016/S1074-7613(00)80305-2)

Figure 2 Immune Tolerance in B6–lpr or B6–gld Mice B6–lpr (A), B6–gld (B), or B6 mice were immunized with 2.5 × 104 pfu of HSV-1 either AC or subcutaneously. They were challenged 7 days later with 106 pfu UV-inactivated virus in 0.033 ml PBS in the right footpad and 0.033ml PBS in the left footpad. Measurements (micrometers ± standard error) were taken 24 hr later and represent the difference between right footpad (antigen challenge) and left footpad (PBS challenge). Background (Bkg) values represent the difference between challenged and unchallenged sites in naive mice. Immunity 1996 5, 7-16DOI: (10.1016/S1074-7613(00)80305-2)

Figure 3 Immune Tolerance and Apoptosis in Chimeric B6→B6–lpr Mice (A) B6, B6–lpr, or B6→B6–lpr chimeric mice were immunized with 2.5 × 104 pfu of HSV-1 either AC or subcutaneously. They were challenged 7 days later with 106 pfu UV-inactivated virus in 0.033 ml PBS in the right footpad and 0.033 ml PBS in the left footpad. Measurements (micrometers ± standard error) were taken 24 hr later and represent the difference between right footpad (antigen challenge) and left footpad (PBS challenge). Background (Bkg) values represent the difference between challenged and unchallenged sites in naive mice. (B) TUNEL stain of inflammatory cells infiltrating the eye of B6→B6–lpr chimeric mice 48 hr after injection of 2.5 × 104 HSV-1. (C) TUNEL stain of inflammatory cells infiltrating the eye B6–lpr mice 48 hr after injection of 2.5 × 104 HSV-1. AC, anterior chamber; C, cornea; IR, iris; L, lens. Immunity 1996 5, 7-16DOI: (10.1016/S1074-7613(00)80305-2)

Figure 3 Immune Tolerance and Apoptosis in Chimeric B6→B6–lpr Mice (A) B6, B6–lpr, or B6→B6–lpr chimeric mice were immunized with 2.5 × 104 pfu of HSV-1 either AC or subcutaneously. They were challenged 7 days later with 106 pfu UV-inactivated virus in 0.033 ml PBS in the right footpad and 0.033 ml PBS in the left footpad. Measurements (micrometers ± standard error) were taken 24 hr later and represent the difference between right footpad (antigen challenge) and left footpad (PBS challenge). Background (Bkg) values represent the difference between challenged and unchallenged sites in naive mice. (B) TUNEL stain of inflammatory cells infiltrating the eye of B6→B6–lpr chimeric mice 48 hr after injection of 2.5 × 104 HSV-1. (C) TUNEL stain of inflammatory cells infiltrating the eye B6–lpr mice 48 hr after injection of 2.5 × 104 HSV-1. AC, anterior chamber; C, cornea; IR, iris; L, lens. Immunity 1996 5, 7-16DOI: (10.1016/S1074-7613(00)80305-2)

Figure 3 Immune Tolerance and Apoptosis in Chimeric B6→B6–lpr Mice (A) B6, B6–lpr, or B6→B6–lpr chimeric mice were immunized with 2.5 × 104 pfu of HSV-1 either AC or subcutaneously. They were challenged 7 days later with 106 pfu UV-inactivated virus in 0.033 ml PBS in the right footpad and 0.033 ml PBS in the left footpad. Measurements (micrometers ± standard error) were taken 24 hr later and represent the difference between right footpad (antigen challenge) and left footpad (PBS challenge). Background (Bkg) values represent the difference between challenged and unchallenged sites in naive mice. (B) TUNEL stain of inflammatory cells infiltrating the eye of B6→B6–lpr chimeric mice 48 hr after injection of 2.5 × 104 HSV-1. (C) TUNEL stain of inflammatory cells infiltrating the eye B6–lpr mice 48 hr after injection of 2.5 × 104 HSV-1. AC, anterior chamber; C, cornea; IR, iris; L, lens. Immunity 1996 5, 7-16DOI: (10.1016/S1074-7613(00)80305-2)

Figure 4 Immune Tolerance Requires Functional Fas Expression on Injected Spleen Cells and Functional FasL Expression in the Eye B6, B6–lpr, or B6–gld mice were injected AC with 5 × 105 TNP–spl from B6, B6–lpr, or B6–gld mice 48 hr before immunization with 1% TNCB on shaved abdominal skin. Mice were challenged 5 days later with 0.033 ml 10 mM TNBS in PBS in the right footpad and 0.033 ml PBS in the left footpad. Measurements (micrometers ± standard error) were taken 24 hr later and represent the difference between right footpad (antigen challenge) and left footpad (PBS challenge). Background (Bkg) values represent the difference between challenged and unchallenged sites in naive mice. Immunity 1996 5, 7-16DOI: (10.1016/S1074-7613(00)80305-2)

Figure 5 TUNEL Stains from Mice 48 hr Post-AC Injection with TNP–spl (A) B6 TNP–spl injected into B6 eyes (B) B6–lpr TNP–spl injected into B6 eyes. (C) B6 TNP–spl injected into B6–gld eyes. AC, anterior chamber; IR, iris; L, lens. Immunity 1996 5, 7-16DOI: (10.1016/S1074-7613(00)80305-2)

Figure 5 TUNEL Stains from Mice 48 hr Post-AC Injection with TNP–spl (A) B6 TNP–spl injected into B6 eyes (B) B6–lpr TNP–spl injected into B6 eyes. (C) B6 TNP–spl injected into B6–gld eyes. AC, anterior chamber; IR, iris; L, lens. Immunity 1996 5, 7-16DOI: (10.1016/S1074-7613(00)80305-2)

Figure 5 TUNEL Stains from Mice 48 hr Post-AC Injection with TNP–spl (A) B6 TNP–spl injected into B6 eyes (B) B6–lpr TNP–spl injected into B6 eyes. (C) B6 TNP–spl injected into B6–gld eyes. AC, anterior chamber; IR, iris; L, lens. Immunity 1996 5, 7-16DOI: (10.1016/S1074-7613(00)80305-2)

Figure 6 Tolerance Induction Requires Apoptotic Cell Death (A) TNP-coupled B6–lpr T cells were freeze/thawed (F/T), γ irradiated (γ-irrad), heated (heat), or fixed with 1% paraformaldehyde (1% Para) prior to AC injection. Mice were immunized 48 hr later with 1% TNCB on shaved abdominal skin. Mice were challenged 5 days later with 0.033 ml 10 mM TNBS in PBS in the right footpad and 0.033 ml PBS in the left footpad. Measurements (micrometers ± standard error) were taken 24 hr later and represent the difference between right footpad (antigen challenge) and left footpad (PBS challenge). Background (Bkg) values represent the difference between challenged and unchallenged sites in naive mice. (B) DNA fragmentation of treated B6–lpr T cells used for injection in (A). Cells (106) were treated as above and cultured overnight before DNA was extracted and resolved on a 2% agarose gel. DNA was visualized by ethidium bromide staining. Lane 1, untreated; lane 2, freeze/thaw; lane 3, γ irradiated; lane 4, heated; lane 5, 1% paraformaldehyde fixed. Immunity 1996 5, 7-16DOI: (10.1016/S1074-7613(00)80305-2)

Figure 6 Tolerance Induction Requires Apoptotic Cell Death (A) TNP-coupled B6–lpr T cells were freeze/thawed (F/T), γ irradiated (γ-irrad), heated (heat), or fixed with 1% paraformaldehyde (1% Para) prior to AC injection. Mice were immunized 48 hr later with 1% TNCB on shaved abdominal skin. Mice were challenged 5 days later with 0.033 ml 10 mM TNBS in PBS in the right footpad and 0.033 ml PBS in the left footpad. Measurements (micrometers ± standard error) were taken 24 hr later and represent the difference between right footpad (antigen challenge) and left footpad (PBS challenge). Background (Bkg) values represent the difference between challenged and unchallenged sites in naive mice. (B) DNA fragmentation of treated B6–lpr T cells used for injection in (A). Cells (106) were treated as above and cultured overnight before DNA was extracted and resolved on a 2% agarose gel. DNA was visualized by ethidium bromide staining. Lane 1, untreated; lane 2, freeze/thaw; lane 3, γ irradiated; lane 4, heated; lane 5, 1% paraformaldehyde fixed. Immunity 1996 5, 7-16DOI: (10.1016/S1074-7613(00)80305-2)

Figure 7 Bcl-xL Expression in T Cells Blocks Tolerance B6 mice were AC injected with TNP–spl cells prepared from normal B6 mice or Bcl-xL transgenic mice 48 hr prior to immunization with 1% TNCB on shaved abdominal skin. Mice were challenged 5 days later with 0.033 ml 10 mM TNBS in PBS in the right footpad and 0.033 ml PBS in the left footpad. Measurements (micrometers ± standard error) were taken 24 hr later and represent the difference between right footpad (antigen challenge) and left footpad (PBS challenge). Background (Bkg) values represent the difference between challenged and unchallenged sites in naive mice. Immunity 1996 5, 7-16DOI: (10.1016/S1074-7613(00)80305-2)